Search Results

FDA

FDA grants Oxehealth Vital Signs De Novo clearance

Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product, which is incorporated into Oxevision, the vision-based patient monitoring and management platform delivered as software as a service.

March 31, 2021

·

2 min read

Deals

Oxehealth Secure Investment to Fund Commercial Expansion

Oxehealth have announced that the company has secured financial commitments totalling £10m, which will be delivered in two rounds across 2021 and 2022.

March 5, 2021

·

2 min read

Oxehealth Uses Cameras To Monitor Your Heartbeat From Across The Room

December 7, 2016

·

1 min read

Oxehealth Wins Funding To Trial Camera-Based Health Monitoring With Broadmoor Hospital

December 16, 2014

·

3 min read

Ex-ARM CEO East Backs Oxehealth’s Vision For Vital Sign Technology Applications

February 6, 2014

·

3 min read

Business

Oxford Biomedical Spin Out, Oxehealth, Recruits Healthcare Chairman to Make Contactless Vital Signs Monitoring a Commercial Reality

September 5, 2013

·

3 min read

MR Vital Sign Monitors Market Growth Pursuant to Rapid AI Penetration: Fact.MR

Surging cases of COPD and cardiovascular diseases is encouraging clinicians and manufacturers to develop AI driven MR vital sign monitors

April 8, 2021

·

5 min read

Business

Silence Therapeutics Strengthens Board with Key Appointments

Silence Therapeutics, PLC (LON: SLN) (“Silence” or “the Company”) a leader in the discovery, development and delivery of novel RNA therapeutics for the treatment of serious diseases, is pleased to announce that Iain Ross has joined as a Non-Executive Director and Chairman of the Board of Directors with immediate effect

April 25, 2019

·

5 min read